Stock comparison
Merck & Co., Inc. is 142.5x more valuable than Palvella Therapeutics, Inc. by market capitalization ($308.78 B vs $2.17 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MRK is larger
Merck & Co., Inc. is 142.5x more valuable than Palvella Therapeutics, Inc. by market capitalization ($308.78 B vs $2.17 B).
Market value leader
MRK
Merck & Co., Inc. is 142.5x more valuable than Palvella Therapeutics, Inc. by market capitalization ($308.78 B vs $2.17 B).
Revenue leader
MRK
PVLA: $42.81M vs MRK: $65.01B.
Profit leader
MRK
PVLA: -$41.72M vs MRK: $18.25B.
Margin leader
MRK
PVLA: -97.4% vs MRK: 28.1% net margin.
| Metric | PVLA | MRK |
|---|---|---|
| Market cap | $2.17 B | $308.78 B |
| US-listed rank | #2073 | #45 |
| Revenue (latest FY) | $42.81M | $65.01B |
| Net income (latest FY) | -$41.72M | $18.25B |
| Net margin | -97.4% | 28.1% |
| P/E (trailing FY) | - | 16.9x |
| SEC filings | 772 | 998 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Merck & Co., Inc. is 142.5x more valuable than Palvella Therapeutics, Inc. by market capitalization ($308.78 B vs $2.17 B).
Full pages: Palvella Therapeutics, Inc. and Merck & Co., Inc., or browse the full rankings.